Proposed strategy to reduce post-transplantation HCV-related disease progression: Marina Berenguer, VAMC/UCSF, San Francisco, CA; Jeffrey Crippin, Washington Univ, San Louis, MO; Nathan Bass, UCSF, San Francisco, CA; Robert Gish, Cal-Pacific Medical Ctr, San Francisco, CA; George Netto, Baylor Medical Ctr, Dallas, TX; Judy Alonzo, VAMC/UCSF, San Francisco, CA; Richard Garcia-Kennedy, Cal-Pacific Medical Ctr, San Francisco, CA; Martin Prieto, La Fe Hosp, Valencia Spain; Jessica Watson, UCSF, San Francisco, CA; Teresa L Wright, VAMC/UCSF, San Francisco, CA